EAM
SNY icon

Eagle Asset Management’s Sanofi SNY Stock Holding History

Eagle Asset Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$338K Buy
6,582
+658
+11% +$35.5K ﹤0.01% 519
2024
Q2 		$294K Buy
5,924
+36
+0.6% +$1.74K ﹤0.01% 553
2024
Q1 		$284K Sell
5,888
-166
-3% -$8.11K ﹤0.01% 557
2023
Q4 		$301K Sell
6,054
-309
-5% -$15.1K ﹤0.01% 534
2023
Q3 		$341K Sell
6,363
-208
-3% -$11.1K ﹤0.01% 511
2023
Q2 		$354K Sell
6,571
-248
-4% -$13.3K ﹤0.01% 512
2023
Q1 		$371K Sell
6,819
-125
-2% -$6.08K ﹤0.01% 514
2022
Q4 		$340K Sell
6,944
-3,554
-34% -$156K ﹤0.01% 511
2022
Q3 		$399K Sell
10,498
-4,577
-30% -$204K ﹤0.01% 513
2022
Q2 		$754K Sell
15,075
-5,511
-27% -$293K ﹤0.01% 504
2022
Q1 		$1.06M Sell
20,586
-1,228
-6% -$63.4K 0.01% 504
2021
Q4 		$1.1M Buy
21,814
+10,338
+90% +$511K ﹤0.01% 522
2021
Q3 		$553K Buy
11,476
+4,645
+68% +$236K ﹤0.01% 547
2021
Q2 		$359K Sell
6,831
-3,290
-33% -$172K ﹤0.01% 563
2021
Q1 		$499K Buy
+10,121
New +$486K ﹤0.01% 544
2020
Q4 		– Sell
-15,479
Closed -$781K – 665
2020
Q3 		$781K Sell
15,479
-669
-4% -$34.4K ﹤0.01% 490
2020
Q2 		$824K Sell
16,148
-206
-1% -$10K ﹤0.01% 498
2020
Q1 		$714K Sell
16,354
-730
-4% -$34.9K ﹤0.01% 543
2019
Q4 		$857K Buy
17,084
+608
+4% +$28.5K ﹤0.01% 570
2019
Q3 		$763K Sell
16,476
-96
-0.6% -$4.14K ﹤0.01% 566
2019
Q2 		$717K Sell
16,572
-570
-3% -$24.2K ﹤0.01% 570
2019
Q1 		$759K Buy
17,142
+594
+4% +$25.4K ﹤0.01% 550
2018
Q4 		$718K Buy
16,548
+4,030
+32% +$178K ﹤0.01% 544
2018
Q3 		$559K Buy
12,518
+5,875
+88% +$251K ﹤0.01% 564
2018
Q2 		$265K Buy
6,643
+392
+6% +$15.4K ﹤0.01% 608
2018
Q1 		$250K Buy
6,251
+636
+11% +$26.5K ﹤0.01% 613
2017
Q4 		$238K Sell
5,615
-5,192
-48% -$239K ﹤0.01% 616
2017
Q3 		$537K Buy
10,807
+4,302
+66% +$208K ﹤0.01% 572
2017
Q2 		$311K Buy
6,505
+739
+13% +$35.3K ﹤0.01% 608
2017
Q1 		$260K Buy
+5,766
New +$245K ﹤0.01% 632

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Eagle Asset Management's SNY Position: Q3 2024 in Review

Eagle Asset Management increased its Sanofi (SNY) stake by 11% in Q3 2024, buying an estimated $35.5K and bringing the position to 6,582 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Eagle Asset Management first reported a position in SNY in Q1 2017 and has held it in 30 quarters since. The position peaked at $1.1M in Q4 2021. 758 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Eagle Asset Management held 6,582 shares of Sanofi worth $338K as of Q3 2024.
  • Eagle Asset Management bought 658 Sanofi shares in Q3 2024, an estimated $35.5K.
  • Sanofi made up ﹤0.01% of Eagle Asset Management's portfolio in Q3 2024, its #519 holding.
  • Eagle Asset Management first reported a position in Sanofi in Q1 2017 and has held it in 30 quarters since.
  • Eagle Asset Management's Sanofi position peaked at $1.1M in Q4 2021.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.